Ocular Surface Center, Miami, Florida 33173, USA.
Ophthalmology. 2013 Jul;120(7):1341-7. doi: 10.1016/j.ophtha.2013.01.001. Epub 2013 May 9.
To evaluate ocular demodicosis as a potential risk factor in pterygium recurrence.
Cross-sectional study to correlate clinical findings with laboratory data.
We retrospectively reviewed 94 patients (43 with primary and 51 with recurrent pterygia), among whom 68 patients received surgical correction, and prospectively enrolled another 23 pterygium patients and 14 nonpterygium controls for measuring the tear level of interleukin (IL)-17.
All patients had microscopically confirmed ocular demodicosis. Statistical correlations were analyzed among age, sex, aqueous tear deficiency, dry eye, ocular demodicosis, follow-up period, surgical outcome, and tear levels of IL-17 measured by enzyme-linked immunosorbent assay.
Correlation between ocular demodicosis or IL-17 levels and pterygium recurrence.
Among 94 patients, ocular demodicosis was more prevalent in patients with recurrent pterygium than those with primary pterygium (P = 0.015). During follow-up of 16.5 ± 11.5 months, 68 postsurgical patients developed 7 corneal recurrences, which constituted 7.4% of primary and 12.2% of recurrent pterygium (P = 0.820). They also developed 8 conjunctival recurrences. Kaplan-Meier survival analysis showed combined (P = 0.000), corneal (P = 0.044), and conjunctival (P = 0.002) recurrence was significantly higher among patients with demodicosis than those without. Conjunctival recurrence occurred within 6 months in eyes without demodicosis but extended beyond 6 months in eyes with demodicosis. In 34 postsurgical patients with demodicosis, the mite count of 14 patients with recurrence was significantly higher than that of 20 without (P = 0.005). The IL-17 level was significantly higher in patients with either pterygium or demodicosis than controls (P = 0.049 and 0.040, respectively), and the IL-17 level was further elevated in patients with both pterygium and demodicosis (all P<0.05).
Ocular demodicosis is a risk factor for pterygium recurrence, especially for conjunctival recurrence, presumably by perpetuating chronic inflammation mediated by T-helper (Th)17 lymphocytes.
评估眼部蠕形螨病是否是翼状胬肉复发的潜在危险因素。
横断面研究,将临床发现与实验室数据相关联。
我们回顾性分析了 94 名患者(43 名原发性和 51 名复发性翼状胬肉),其中 68 名患者接受了手术矫正,前瞻性纳入了另外 23 名翼状胬肉患者和 14 名非翼状胬肉对照组,以测量白细胞介素(IL)-17 的泪液水平。
所有患者均经显微镜证实存在眼部蠕形螨病。通过酶联免疫吸附试验分析年龄、性别、水样泪液缺乏、干眼症、眼部蠕形螨病、随访时间、手术结果以及 IL-17 泪液水平之间的统计学相关性。
眼部蠕形螨病或 IL-17 水平与翼状胬肉复发之间的相关性。
在 94 名患者中,复发性翼状胬肉患者的眼部蠕形螨病患病率高于原发性翼状胬肉患者(P=0.015)。在 16.5±11.5 个月的随访中,68 名术后患者发生 7 例角膜复发,其中原发性和复发性翼状胬肉分别占 7.4%和 12.2%(P=0.820)。他们还发生了 8 例结膜复发。Kaplan-Meier 生存分析显示,合并(P=0.000)、角膜(P=0.044)和结膜(P=0.002)复发在蠕形螨病患者中明显高于无蠕形螨病患者。无蠕形螨病患者的结膜复发发生在 6 个月内,而有蠕形螨病患者的结膜复发则延长至 6 个月以上。在 34 名术后有蠕形螨病的患者中,14 例复发患者的螨虫计数明显高于 20 例无复发患者(P=0.005)。翼状胬肉或蠕形螨病患者的白细胞介素(IL)-17 水平均明显高于对照组(P=0.049 和 0.040),同时患有翼状胬肉和蠕形螨病的患者的白细胞介素(IL)-17 水平进一步升高(均 P<0.05)。
眼部蠕形螨病是翼状胬肉复发的危险因素,特别是结膜复发的危险因素,可能是通过 T 辅助(Th)17 淋巴细胞介导的慢性炎症持续存在所致。